Abstract
Hypoactive sexual desire disorder (HSDD) is defined as persistent deficient sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty and is not better accounted for by another psychiatric disorder or substance, medication, or medical condition. HSDD affects 10 % of women ages 18 and older. HSDD is associated with lower health-related quality of life, lower general happiness and relationship satisfaction, and low self-esteem. HSDD is underdetected; important areas for diagnostic evaluation include screening for depression, medications, relationship satisfaction, and androgen status. The decreased sexual desire screener is a tool for detecting and diagnosing HSDD, validated for use in primary care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970–8.
Diagnostic and statistical manual for mental disorders. 4th ed. rev.: DSM-IV-R. Washington, DC: American Psychiatric Association; 2003.
Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
Basson R, Leiblum S, Brotto L, et al. Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol. 2003;24(4):221–9.
World Health Organization: international statistical classification of diseases and related health problems. 10th Revision, Edition 2010 (4th ed. ICD-10). Geneva: WHO Press, World Health Association; 2011.
Master WH, Johnson VE. Human sexual response. Boston, MA: Little Brown, Co.; 1966.
Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther. 1977;3(1):3–9.
Leif HI. Inhibited sexual desire. Med Aspects Hum Sex. 1977;7:94–5.
Basson R. Women’s sexual function and dysfunction: current uncertainties, future directions. Int J Impot Res. 2008;20(5):466–78.
Giraldi A, Kristensen E, Sand M. Endorsement of models describing sexual response of men and women with a sexual partner: an online survey in a population sample of Danish adults ages 20–65 years. J Sex Med. 2015;12(1):116–28. doi:10.1111/jsm.12720. Epub 2014 Nov 3.
West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med. 2008;168(13):1441–9.
Hayes RD, Dennerstein L, Bennett CM, Koochaki PE, Leiblum SR, Graziottin A. Relationship between hypoactive sexual desire disorder and aging. Fertil Steril. 2007;87(1):107–12.
Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28(4):317–30.
Maserejian NN, Shifren J, Parish SJ, Segraves RT, Huang L, Rosen RC. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther. 2012;38(1):41–62.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–44.
Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the women’s international study of health and sexuality (WISHeS). Menopause. 2006;13(1):46–56.
Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med. 2009;6(6):1549–60.
Clayton AH, Maserejian NN, Connor MK, Huang L, Heiman JR, Rosen RC. Depression in premenopausal women with HSDD: baseline findings from the HSDD registry for women. Psychosom Med. 2012;74(3):305–11.
Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep. 2002;2(3):182–7.
Clayton AH, Balon R. The impact of mental illness and psychotropic medications on sexual functioning: the evidence and management. J Sex Med. 2009;6(5):1200–11.
Pfaus JG. Pathways of sexual desire. J Sex Med. 2009;6:1506–33.
Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: current status and future directions. J Sex Res. 2009;46(2):121–42.
Pfaus JG. Pathways of sexual desire. J Sex Med. 2009;6(6):1506–33.
Jeong GW, Park K, Youn G, et al. Assessment of cerebrocortical regions associated with sexual arousal in premenopausal and menopausal women by using BOLD-based functional MRI. J Sex Med. 2005;2(5):645–51.
Perelman MA. The sexual tipping point: a mind/body model for sexual medicine. J Sex Med. 2009;6:629–32.
Dunn KM, Croft PR, Hackett GI. Satisfaction in the sex life of a general population sample. J Sex Marital Ther. 2000;26(2):141–51.
Fisher W, Rosen R, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: the female experience of men’s attitudes to life events and sexuality (FEMALES) study. J Sex Med. 2005;2(5):675–84.
Litzinger S, Gordon KC. Exploring relationships among communication, sexual satisfaction, and marital satisfaction. J Sex Marital Ther. 2005;31(5):409–24.
Witting K, Santtila P, Varjonen M, et al. Female sexual dysfunction, sexual distress, and compatibility with partner. J Sex Med. 2008;5(11):2587–99.
Metz ME, Epstein N. Assessing the role of relationship conflict in sexual dysfunction. J Sex Marital Ther. 2002;28(2):139–64.
Rellini AH, Ing AD, Meston CM. Implicit and explicit cognitive sexual processes in survivors of childhood sexual abuse. J Sex Med. 2011;8(11):3098–107. doi:10.1111/j.1743-6109.2011.02356.x. Epub 2011 Jun 16.
Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al. Transdermal testosterone treatment in women with impaired sexual function after oopherectomy. N Engl J Med. 2000;343:682–8.
Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847–53.
Davis SR. Androgen use for low sexual desire in midlife women. Menopause. 2013;20(7):795–7.
Bancroft J. Sexual effects of androgens in women: some theoretical considerations. Fertil Steril. 2002;77 Suppl 4:S55–9.
Bachmann GA, Leiblum SR. Sexuality in sexagenarian women. Maturitas. 1991;13(1):43–50.
Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation. J Clin Endocrinol Metab. 2005;90(8):4836–45.
Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005;294(1):91–6.
Gerber JR, Johnson JV, Bunn JY, O’Brien SL. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause. Fertil Steril. 2005;83(3):643–8.
Wåhlin-Jacobsen S, Pedersen AT, Kristensen E, Laessøe NC, Lundqvist M, Cohen AS, et al. Is there a correlation between androgens and sexual desire in women? J Sex Med. 2015;12(2):358–73. doi:10.1111/jsm.12774. Epub 2014 Dec 5.
Dennerstein L, Hayes R. Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause. J Sex Med. 2005;2 Suppl 3:118–32.
Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006;91(10):3697–710.
Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354:1497–506.
Graham CA, Bancroft J, Doll HA, Greco T, Tanner A. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology. 2007;32(3):246–55.
Panzer C, Wise S, Fantini G, et al. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med. 2006;3(1):104–13.
Caruso S, Agnello C, Intelisano G, Farina M, Di ML, Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception. 2004;69(3):237–40.
Bohm-Starke N, Johannesson U, Hilliges M, Rylander E, Torebjork E. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? J Reprod Med. 2004;49(11):888–92.
Goldstein AT, Burrows L. Vulvodynia. J Sex Med. 2008;5(1):5–14; quiz 15. doi:10.1111/j.1743-6109.2007.00679.x.
Goldstein AT, Belkin ZR, Krapf JM, Song W, Khera M, Jutrzonka SL, Kim NN, Burrows LJ, Goldstein I. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014;11(11):2764–71. doi:10.1111/jsm.12668. Epub 2014 Sep 4.
Davis AR, Castano PM. Oral contraceptives and libido in women. Annu Rev Sex Res. 2004;15:297–320.
Stuckey BG. Female sexual function and dysfunction in the reproductive years: the influence of endogenous and exogenous sex hormones. J Sex Med. 2008;5(10):2282–90.
Clayton AH, Goldfischer ER, Goldstein I, Derogatis L, Lewis-D’Agostino DJ, Pyke R. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med. 2009;6:730–8.
Clayton AH. Sexual function and dysfunction in women. Psychiatr Clin N Am. 2003;26:673–82.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
DeRogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5(2):357–64. Epub 2007 Nov 27.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Parish, S.J., Hahn, S.R. (2016). The Epidemiology and Diagnosis of Hypoactive Sexual Desire Disorder and Causes of HSDD: Situational, Depression, Drugs, Chronic Illnesses, and Hormonal Depletion. In: Lipshultz, L., Pastuszak, A., Goldstein, A., Giraldi, A., Perelman, M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3100-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3100-2_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3099-9
Online ISBN: 978-1-4939-3100-2
eBook Packages: MedicineMedicine (R0)